IWC
ATHE

Integrated Wealth Concepts’s Alterity Therapeutics ATHE Stock Holding History

Integrated Wealth Concepts’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392 Buy
+73
New +$318 ﹤0.01% 5680

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $660M AUM 17.81% 1-Year Est. Return

Integrated Wealth Concepts's ATHE Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Alterity Therapeutics (ATHE) in Q2 2026: 73 shares worth $392. The stake represents ﹤0.01% of the portfolio and ranks #5680 among its holdings.

21 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

  • Integrated Wealth Concepts held 73 shares of Alterity Therapeutics worth $392 as of Q2 2026.
  • Alterity Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Alterity Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5680 holding.
  • 21 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.